SPPI News and Press, Spectrum Pharmaceuticals Inc. From 08/10/20

Spectrum Pharmaceuticals (NASDAQ: SPPI ) : Q2 GAAP EPS of -$0.29 beats by $0.03 . cash, cash equivalents, and marketable securities of $156.5M Press Release More news on: Spectrum Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news,

Recently announced positive topline results in HER2 exon 20 insertion mutations from Cohort 2 of the poziotinib ZENITH20 trial Company is in process of requesting a pre-NDA meeting with the FDA seeking an indication for second-line NSCLC patients with HER2 exon 20 insertion mutations ...

Spectrum Pharmaceuticals, Inc. (Nasdaq: SPPI) (“Spectrum” or the “Company”), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced that the underwriters of its previously announced public offering of common stock have fully e...

Spectrum Pharmaceuticals (NasdaqGS: SPPI) a biopharmaceutical company focused on novel and targeted oncology therapies, today announced it will host a conference call to discuss the second quarter 2020 financial results and provide a corporate update on Monday, August 10, 2020 at 4:30 p.m. Ea...

Shares of Spectrum Pharmaceuticals (NASDAQ: SPPI) , a small-cap biopharmaceutical company that focuses on cancer treatments, are down by 20.2% as of 12:18 p.m. EDT on Thursday, after the drugmaker announced the pricing of a public offering of common stock before the market opened today. Natur...

Gainers:  Taoping (NASDAQ: TAOP ) +492% . More news on: Taoping Inc., Edesa Biotech, Inc., DIRTT Environmental Solutions Ltd., Stocks on the move, , Read more ...

Spectrum Pharmaceuticals (NASDAQ: SPPI )   -18%  after pricing equity offering. More news on: Spectrum Pharmaceuticals, Inc., Global Eagle Entertainment Inc., JAKKS Pacific, Inc., Stocks on the move, , Read more ...

Spectrum Pharmaceuticals (NASDAQ: SPPI ) prices its public offering of ~21.7M common shares at $3.00 per share. Underwriters' over-allotment is an additional ~3.3M shares. Closing date is August 3. More news on: Spectrum Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move...

Spectrum Pharmaceuticals, Inc. (Nasdaq: SPPI) (“Spectrum” or the “Company”), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced the pricing of an underwritten public offering of 21,666,667 shares of its common stock at a p...

Spectrum Pharmaceuticals, Inc. (Nasdaq-GS: SPPI) (“Spectrum”), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced that it intends to offer and sell shares of its common stock in an underwritten registered public offering. All of the sha...